Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies
NI Mazur, MT Caballero, MC Nunes - The Lancet, 2024 - thelancet.com
The global burden of respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI)
in young children is high. The RSV prevention strategies approved in 2023 will be essential …
in young children is high. The RSV prevention strategies approved in 2023 will be essential …
Early-life respiratory syncytial virus disease and long-term respiratory health
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection
(LRTI), hospital admission, and mortality in children worldwide. Early-life RSV LRTI has also …
(LRTI), hospital admission, and mortality in children worldwide. Early-life RSV LRTI has also …
Global, regional, and national burden of preterm birth, 1990–2021: a systematic analysis from the global burden of disease study 2021
X Liang, Y Lyu, J Li, Y Li, C Chi - EClinicalMedicine, 2024 - thelancet.com
Background Preterm birth and its complications are leading causes of mortality among
children under five years of age. Given the increasing burden of preterm birth on neonatal …
children under five years of age. Given the increasing burden of preterm birth on neonatal …
[HTML][HTML] Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity …
AS Mandviwala, ALW Huckriede, VA Arankalle… - Virology, 2024 - Elsevier
RSV infection remains a serious threat to the children all over the world, especially, in the
low-middle income countries. Vaccine delivery via the mucosa holds great potential for …
low-middle income countries. Vaccine delivery via the mucosa holds great potential for …
Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina
G Guiñazú, J Dvorkin, S Mahmud, R Baral, C Pecenka… - Vaccine, 2024 - Elsevier
Background. New interventions are available for the prevention of respiratory syncytial virus
(RSV) disease in young infants. We aimed to assess the potential impact and cost …
(RSV) disease in young infants. We aimed to assess the potential impact and cost …
The Need for RSV Prophylaxis in LMICs
C Pérez Casas, A Tagarro, Q Bassat, P Rojo - Pediatrics, 2024 - publications.aap.org
Respiratory syncytial virus (RSV) is a leading cause of hospitalization in infants and young
children because of lower respiratory tract illness, encompassing bronchiolitis and …
children because of lower respiratory tract illness, encompassing bronchiolitis and …
Born too soon and vulnerable: the disproportionate burden of RSV among preterm babies in LMICs
D Torres Fernandez… - The Lancet, 2024, vol. 403 …, 2024 - diposit.ub.edu
1 Title: Born to soon and vulnerable: The disproportionate burden of Respiratory Syncytial Virus
among Preterm babies in low- an Page 1 1 Title: Born to soon and vulnerable: The …
among Preterm babies in low- an Page 1 1 Title: Born to soon and vulnerable: The …